The weekly litigation news digest is live. Subscribe now

IP Verse

Sirp-Alpha Immunoglobulin Fusion Proteins - EP3180363

The patent EP3180363 was granted to Merck Patent on Sep 14, 2022. The application was originally filed on Aug 14, 2015 under application number EP15750744A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3180363

MERCK PATENT
Application Number
EP15750744A
Filing Date
Aug 14, 2015
Status
Patent Maintained As Amended
Aug 12, 2022
Publication Date
Sep 14, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SCRIPTJun 24, 2020SCRIPT -

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2015266942
INTERNATIONAL-SEARCH-REPORTUS2014161805
INTERNATIONAL-SEARCH-REPORTWO2010130053
INTERNATIONAL-SEARCH-REPORTWO2014121093
OPPOSITIONUS2003026803
OPPOSITIONWO2009046541
OPPOSITIONWO2009131453
OPPOSITIONWO2010070047
OPPOSITIONWO2010130053
OPPOSITIONWO2013109752
OPPOSITIONWO2014094122
OPPOSITIONWO2014121093
OTHEREP3180363
OTHERWO2014121093
OTHERWO2015148416

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents